Skip to main content
GANX logo

GANX · Gain Therapeutics, Inc.

Track GANX — free
$1.91 -0.09 (-4.50%) At close · Aug 25
Market Cap
$87.51M
Shares
43.64M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 49
Total Value: $17,848,298
Total Shares: 8,792,275

Institutional Ownership Trend

22 quarters

Holder Concentration

Across 49 13F filers · Δ vs Mar 31, 2026
Top Holder
21.9%
Sep 2023 → Jun 2026 · range 16.1% – 38.7%
−0.5 pts
Top 5
53.2%
Sep 2023 → Jun 2026 · range 53.2% – 83.2%
−4.2 pts
Top 10
76.0%
Sep 2023 → Jun 2026 · range 76.0% – 96.4%
−3.0 pts
HHI
886
Sep 2023 → Jun 2026 · range 885 – 1,921
Broadly held−79

Quarterly Activity

vs Mar 31, 2026
New
14
Increased
13
Decreased
9
Sold Out
5
Unchanged
13
Holder count: +9
Institutional value: +16.2%
Shares held: +11.1%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 53 of 53
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1819411 CUSIP 36269B105 13F (30d) 45 filings 45 filers Visit website Investor relations